IGF1R and cancer: In other studies, treatments that target IGF-1R were found to sensitize cancer cells to irradiation, and kinase-deficient mutant IGF-1R cancer cells exhibited significantly decreased growth and viability and reduced clonogenic survival after irradiation compared with wild-type cells [42,85].